Literature DB >> 20516203

Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin.

Jeannine Sauber1, Jessica Grothe, Maria Behm, André Scherag, Harald Grallert, Thomas Illig, Anke Hinney, Johannes Hebebrand, Susanna Wiegand, Annette Grüters, Heiko Krude, Heike Biebermann.   

Abstract

OBJECTIVE: In the past 20 years, obesity has become a major health problem due to associated diseases like type 2 diabetes mellitus. The gastric inhibitory polypeptide receptor (GIPR) modulates body weight and glucose homeostasis and, therefore, represents an interesting candidate gene for obesity and the comorbidity impaired glucose homeostasis. Recently, a GIPR variation was found to be associated with impaired insulin response in humans. In this study, we screened the GIPR gene for mutations and examined the association between three single-nucleotide polymorphisms (SNPs; rs8111428, rs2302382, rs1800437) and childhood obesity, as well as impaired glucose homeostasis.
METHODS: The coding region of the GIPR was screened for mutations by direct sequencing. We genotyped three known SNPs in 2280 healthy normal weight (1696) and obese (584) children and adolescents. Genotyping was performed using the SNaPshot protocol, the iplex, and matrix-assisted laser desorption ionization time-of-flight spectrometry technique. Obesity was defined by a body mass index SDS above 2; homeostatic model assessment was calculated.
RESULTS: No evidence for an association was found between the SNPs and the obesity phenotype. Significant association was found between the minor allele C of the SNP rs1800437 and elevated homeostasis model of insulin resistance values (P=0.001). No further sequence variations in the GIPR were found to be associated with childhood obesity.
CONCLUSION: Variations of the GIPR sequence are not associated with childhood obesity. This study points to a potential role for rs1800437 in glucose homeostasis. Further studies are necessary to confirm these results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516203     DOI: 10.1530/EJE-10-0444

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  5 in total

1.  Downregulation of a GPCR by β-Arrestin2-Mediated Switch from an Endosomal to a TGN Recycling Pathway.

Authors:  Nazish Abdullah; Muheeb Beg; David Soares; Jeremy S Dittman; Timothy E McGraw
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

2.  A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.

Authors:  Sameer Mohammad; Rajesh T Patel; Joanne Bruno; Muhammad Siyab Panhwar; Jennifer Wen; Timothy E McGraw
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

3.  The effect of glucose-dependent insulinotropic polypeptide (GIP) variants on visceral fat accumulation in Han Chinese populations.

Authors:  T Wang; X Ma; T Tang; K Higuchi; D Peng; R Zhang; M Chen; J Yan; S Wang; D Yan; Z He; F Jiang; Y Bao; W Jia; K Ishida; C Hu
Journal:  Nutr Diabetes       Date:  2017-05-22       Impact factor: 5.097

Review 4.  Metabolic regulation through the endosomal system.

Authors:  Jerome Gilleron; Jantje M Gerdes; Anja Zeigerer
Journal:  Traffic       Date:  2019-06-24       Impact factor: 6.215

5.  Genetic Variability of Incretin Receptors and Alcohol Dependence: A Pilot Study.

Authors:  Evangelia Eirini Tsermpini; Katja Goričar; Blanka Kores Plesničar; Anja Plemenitaš Ilješ; Vita Dolžan
Journal:  Front Mol Neurosci       Date:  2022-06-09       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.